Hims & Hers Health, Inc.

Healthcare

NYSE:HIMS · New York Stock Exchange

Market Cap $7.11B Beta 2.40 P/E (TTM) -569.3

$35.47 +3.47%

+$1.11 today

52W Low $13.74High $70.43

Vol 31.64M · Avg 26.18M

EPS (TTM) -$0.06Medical - Equipment & Services

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-15.51%

Period High

$66.18

Period Low

$14.52

Latest

$35.47

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Moderna, Inc.

NASDAQ:MRNA

$25.66B

Align Technology, Inc.

NASDAQ:ALGN

$12.52B

Penumbra, Inc.

NYSE:PEN

$12.46B

Revvity, Inc.

NYSE:RVTY

$10.99B

BioMarin Pharmaceutical Inc.

NASDAQ:BMRN

$10.66B

Baxter International Inc.

NYSE:BAX

$10.22B

The Ensign Group, Inc.

NASDAQ:ENSG

$9.14B

Bio-Techne Corporation

NASDAQ:TECH

$8.70B

Qiagen N.V.

NYSE:QGEN

$7.50B

HealthEquity, Inc.

NASDAQ:HQY

$7.17B

What is the latest HIMS filing?

The latest filing shown is 4 dated Jun 17, 2026.

How many recent filings does HIMS have?

Intrinsic Alpha currently shows 20 recent filings for HIMS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.